Core Insights - The seventh IHMD China International High-end Medical Device Forum was held in Shanghai, highlighting the emergence of Junpu Intelligent Manufacturing Co., Ltd. as a leader in the medical manufacturing sector [1][6] - The forum's theme of "systematic collaborative innovation from R&D to manufacturing" aligns with Junpu Intelligent's strategic focus, showcasing its recent significant orders in the medical field [6] Company Developments - Junpu Intelligent secured important contracts, including a high-precision insulin pen UV laser marking project from a leading domestic pharmaceutical company, capable of producing up to 80 units per minute [6] - The company also won an assembly testing project for HIV detection medical products from a top U.S. medical device firm, emphasizing its ability to deliver high-throughput microfluidic product production lines [6] Product Innovations - The insulin pen automation testing system features a fully automated solution with a cycle time of 48 seconds and a detection efficiency of 1.25 units per minute, adhering to ISO14644-1 Class 8 cleanroom standards [8] - The automatic injector final assembly line operates with a cycle time of 2 seconds and an assembly efficiency of 30 units per minute, incorporating quality control measures to ensure precision and reliability [10] - The inhaler assembly line, designed for the final assembly stage, achieves a production pace of 3.33 seconds per unit and an efficiency of 18 units per minute, also meeting stringent cleanroom standards [12] Strategic Vision - Junpu Intelligent's approach combines flexibility, automation, and compliance, demonstrating the practical value of its manufacturing path through successful product solutions and major orders [14] - The company aims to continue advancing in the healthcare sector, leveraging cutting-edge technology to address industry challenges and explore new manufacturing possibilities in collaboration with global medical partners [14]